Apathy in patients with Parkinson's disease following deep brain stimulation of the subthalamic nucleus

CNS Spectrums

Volumn 21, Issue 3, 2016, Pages 258-264

  Fisher, Isabel Hindle ^a   Pall, Hardev S ^b   Mitchell, Rosalind D ^c   Kausar, Jamilla ^c   Cavanna, Andrea E ^b,d,e  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^d BIRMINGHAM AND SOLIHULL MENTAL HEALTH NHS FOUNDATION TRUST   (United Kingdom)

^e ASTON UNIVERSITY   (United Kingdom)

Author keywords

Apathy; behavior; deep brain stimulation; Parkinson's disease; quality of life; subthalamic nucleus

Indexed keywords

ADULT; AGED; APATHY; APATHY SCALE; BRAIN DEPTH STIMULATION; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; LILLE APATHY RATING SCALE; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC EXAMINATION; PARKINSON DISEASE; PARKINSON DISEASE QUESTIONNAIRE; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SUBTHALAMIC NUCLEUS BRAIN DEPTH STIMULATION; CASE CONTROL STUDY; MIDDLE AGED; PSYCHOLOGY; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SUBTHALAMIC NUCLEUS;

ANTIPARKINSON AGENT;

AGED; ANTIPARKINSON AGENTS; APATHY; CASE-CONTROL STUDIES; DEEP BRAIN STIMULATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; PREVALENCE; QUALITY OF LIFE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SUBTHALAMIC NUCLEUS;

EID: 84965075950     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852916000171     Document Type: Conference Paper

References (43)

1. Leroi I, David A, Robert P. Apathy in Parkinson's disease. In: Ebmeier KP, O'Brian JT, Taylor JP, eds. Psychiatry of Parkinson's Disease: Advances in Biological Psychiatry. Basel: Karger; 2012: 27-40.
2. Benoit M, Andrieu S, Lechowski L. Apathy and depression in Alzheimer's disease are associated with functional deficit and psychotropic prescription. Int J Geriatr Psychiatry. 2008; 23(4): 409-414.
3. Diamond A, Jankovic J. The effect of deep brain stimulation on quality of life in movement disorders. J NeurolNeurosurg Psychiatry. 2005; 76(9): 1188-1193.
4. Barone P, Antonini A, Colosimo C, et al. The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. Mov Disord. 2009; 24(11): 1641-1649.
5. Ceravolo R, Pagni C, Tognoni G, Bonuccelli U. The epidemiology and clinical manifestations of dysexecutive syndrome in Parkinson's disease. Front Neurol. 2012; 3: 159.
6. Antonini A, Barone P, Marconi R, et al. The progression of nonmotor symptoms in Parkinson's disease and their contribution to motor disability and quality of life. J Neurol. 2012; 259(12): 2621-2631.
7. Thobois S, Ardouin C, Lhommée E, et al. Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation. Brain. 2010; 133(Pt 4): 1111-1127.
8. Funkiewiez A, Ardouin C, Caputo E, et al. Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2004; 75(6): 834-839.
9. Kirsch-Darrow L, Zahodne L, Marsiske M, Okun MS, Foote KD, Bowers D. The trajectory of apathy after deep brain stimulation: from pre-surgery to 6 months post-surgery in Parkinson's disease. Parkinsonism Relat Disord. 2011; 17(3): 182-188.
10. Drapier D, Drapier S, Sauleau P, et al. Does subthalamic nucleus stimulation induce apathy in Parkinson's disease? J Neurol. 2006; 253(8): 1083-1091.
11. Denheyer M, Kiss Z, Haffenden A. Behavioral effects of subthalamic deep brain stimulation in Parkinson's disease. Neuropsychologia. 2009; 47(14): 3203-3209.
12. Porat O, Cohen O, Schwartz R, Hassin-Baer S. Association of preoperative symptom profile with psychiatric symptoms following subthalamic nucleus stimulation in patients with Parkinson's disease. J Neuropsychiatry Clin Neurosci. 2009; 21(4): 398-405.
13. Saint-Cyr J, Trepanier L, Kumar R, Lozano AM, Lang AE. Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease. Brain. 2000; 123(Pt 10): 2091-2108.
14. Drapier D, Péron J, Leray E, et al. Emotion recognition impairment and apathy after subthalamic nucleus stimulation in Parkinson's disease have separate neural substrates. Neuropsychologia. 2008; 46(11): 2796-2801.
15. Le Jeune F, Drapier D, Bourguignon A, et al. Subthalamic nucleus stimulation in Parkinson disease induces apathy: a PET study. Neurology. 2009; 73(21): 1746-1751.
16. Funkiewiez A, Ardouin C, Cools R, et al. Effects of levodopa and subthalamic nucleus stimulation on cognitive and affective functioning in Parkinson's disease. Mov Disord. 2006; 21(10): 1656-1662.
17. Krack P, Batir A, Van Blercom N, et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med. 2003; 349(20): 1925-1934.
18. Campbell M, Black K, Weaver P, et al. Mood response to deep brain stimulation of the subthalamic nucleus in Parkinson's disease. J Neuropsychiatry Clin Neurosci. 2012; 24(1): 28-36.
19. Czernecki V, Pillon B, Houeto J, et al. Does bilateral high-frequency stimulation of the subthalamic nucleus aggravate apathy in Parkinson's disease? J Neurol Neurosurg Psychiatry. 2005; 76(6): 775-779.
20. Castelli L, Lanotte M, Zibetti M, et al. Apathy and verbal fluency in STN-stimulated PD patients: an observational follow-up study. J Neurol. 2007; 254(9): 1238-1243.
21. Castelli L, Perozzo P, Zibetti M, et al. Chronic deep brain stimulation of the subthalamic nucleus for Parkinson's disease: effects on cognition, mood, anxiety and personality traits. Eur Neurol. 2006; 55(3): 136-144.
22. Chou L, Persad C, Patil P. Change in fatigue after bilateral subthalamic nucleus deep brain stimulation for Parkinson's disease. Parkinsonism Relat Disord. 2012; 18(5): 510-513.
23. National Parkinson Foundation Parkinson's Toolkit. http://www. toolkit.parkinson.org/sites/toolkit.parkinson.org/files/resources/ UK%20PDS%20Brain%20Bank%20Diagnosis%20Criteria-1.pdf. Accessed August 11, 2014.
24. Tomlinson C, Stowe R, Patel S, Rick C, Gray R, Clarke CE. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord. 2010; 25(15): 2649-2653.
25. Leentjens A, Dujardin K, Marsh L. Apathy and anhedonia rating scales in Parkinson's disease: critique and recommendations. Mov Disord. 2008; 23(14): 2004-2013.
26. The Movement Disorder Society Rating Scales. http://www. movementdisorders.org/publications/rating-scales/. Accessed August 11, 2014.
27. Drijgers R, Dujardin K, Reijnders J, Defebvre L, Leentjens AF. Validation of diagnostic criteria for apathy in Parkinson's disease. Parkinsonism Relat Disord. 2010; 16(10): 656-660.
28. Zahodne L, Young S, Kirsch-Darrow L, et al. Examination of the Lille Apathy Rating Scale in Parkinson disease. Mov Disord. 2009; 24(5): 677-683.
29. Peto V, Jenkinson C, Fitzpatrick R, Greenhall R. The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease. Qual Life Res. 1995; 4(3): 241-248.
30. Kirsch-Darrow L, Zahodne L, Hass C, et al. How cautious should we be when assessing apathy with the Unified Parkinson's Disease Rating Scale? Mov Disord. 2009; 24(5): 684-688.
31. Weaver F, Follett K, Stern M, et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease. JAMA. 2009; 301(1): 63-73.
32. Kleiner-Fisman G, Stern M, Fisman D. Health-related quality of life in Parkinson disease: correlation between Health Utilities Index III and Unified Parkinson's Disease Rating Scale (UPDRS) in U.S. male veterans. Health Qual Life Outcomes. 2010; 8: 91.
33. Lyons K, Pahwa R. Long-term benefits in quality of life provided by bilateral subthalamic stimulation in patients with Parkinson disease. J Neurosurg. 2005; 103(2): 252-255.
34. Soha S, Morrisa M, McGinley J. Determinants of health-related quality of life in Parkinson's disease: a systematic review. Parkinsonism Relat Disord. 2011; 17(1): 1-9.
35. Pederson A, Alves G, Brønnick K, Aarsland D, Tysnes OB, Larsen JP. Apathy in drug-naive patients with incident Parkinson's disease: the Norwegian Park West study. J Neurol. 2010; 257(2): 217-223.
36. Cubo E, Benito-León J, Coronell C, Armesto D, ANIMO Study Group. Clinical correlates of apathy in patients recently diagnosed with Parkinson's disease: the ANIMO study. Neuroepidemiology. 2012; 38(1): 48-55.
37. Pederson K, Larsen J, Alves G, Aarsland D. Prevalence and clinical correlates of apathy in Parkinson's disease: a communitybased study. Parkinsonism Relat Disord. 2009; 15(4): 295-299.
38. Robert G, Le Jeune F, Lozachmeur C, et al. Apathy in patients with Parkinson disease without dementia or depression: a PET study. Neurology. 2012; 79(11): 1155-1160.
39. Higuchi MA, Tsuboi Y, Inoue T, et al. Predictors of the emergence of apathy after bilateral stimulation of the subthalamic nucleus in patients with Parkinson's disease. Neuromodulation. 2015; 18(2): 113-117.
40. Kirsch-Darrow L, Marsiske M, Okun M, Bauer R, Bowers D. Apathy and depression: separate factors in Parkinson's disease. J Int Neuropsychol Soc. 2011; 17(6): 1058-1066.
41. Czernecki V, Pillon B, Houeto J, Pochon JB, Levy R, Dubois B. Motivation, reward, and Parkinson's disease: influence of dopatherapy. Neuropsychologia. 2002; 40(13): 2257-2267.
42. Lozachmeur C, Drapier S, Robert G, et al. Pallidal stimulation in Parkinson's disease does not induce apathy. J Neuropsychiatry Clin Neurosci. 2014; 26(3): 221-226.
43. Martinez-Fernandez R, Pelissier P, Quesada JL, et al. Postoperative apathy can neutralise benefits in quality of life after subthalamic stimulation for Parkinson's disease. J Neurol Neurosurg Psychiatry. 2016; 87: 311-318.